TSENG YUFENG JANE has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, computer technology and organic fine chemistry are J PHARMA CO LTD, VERKMAN ALAN S and FUJIAN MINDONG REJUVENATION PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Singapore | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Computer technology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Biotechnology | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Bioinformatics | |
#5 | Enzymes | |
#6 | Measuring microorganism processes | |
#7 | Computational chemistry | |
#8 | Heterocyclic compounds | |
#9 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Tseng Yufeng Jane | 14 |
#2 | Liu Yu-Li | 10 |
#3 | Sun Chung-Ming | 10 |
#4 | Liu Chih-Min | 10 |
#5 | Hwu Hai-Gwo | 10 |
#6 | Lai Wen-Sung | 8 |
#7 | Lai Wen Sung | 3 |
#8 | Liu Yu Li | 3 |
#9 | Liu Chih Min | 3 |
#10 | Hwu Hai Gwo | 3 |
Publication | Filing date | Title |
---|---|---|
CA3036250A1 | Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors | |
KR20160147868A | Use of known compounds as d-amino acid oxidase inhibitors | |
TW201500754A | Method and system for baseline correction of nuclear magnetic resonance spectrum |